Works matching DE "BREAKTHROUGH infections"
Results: 799
Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial.
- Published in:
- PLoS Medicine, 2022, v. 19, n. 6, p. 1, doi. 10.1371/journal.pmed.1004024
- By:
- Publication type:
- Article
Supra trigonal ureteric reimplantation with detrusorraphy (STURDY) as a novel technique for common sheath reimplantation of duplication anomalies.
- Published in:
- World Journal of Urology, 2024, v. 43, n. 1, p. 1, doi. 10.1007/s00345-024-05401-7
- By:
- Publication type:
- Article
Effector CD8 T cell differentiation in primary and breakthrough SARS-CoV-2 infection in mice.
- Published in:
- Communications Biology, 2025, v. 8, n. 1, p. 1, doi. 10.1038/s42003-025-07820-7
- By:
- Publication type:
- Article
SARS-CoV-2 JN.1 variant evasion of IGHV3-53/3-66 B cell germlines.
- Published in:
- Science Immunology, 2024, v. 9, n. 98, p. 1, doi. 10.1126/sciimmunol.adp9279
- By:
- Publication type:
- Article
SARS-CoV-2 inflammation durably imprints memory CD4 T cells.
- Published in:
- Science Immunology, 2024, v. 9, n. 96, p. 1, doi. 10.1126/sciimmunol.adj8526
- By:
- Publication type:
- Article
Omicron BA.2 breakthrough infection elicits CD8<sup>+</sup> T cell responses recognizing the spike of later Omicron subvariants.
- Published in:
- Science Immunology, 2024, v. 9, n. 91, p. 1, doi. 10.1126/sciimmunol.ade6132
- By:
- Publication type:
- Article
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs.
- Published in:
- Science Immunology, 2023, v. 8, n. 90, p. 1, doi. 10.1126/sciimmunol.abp8966
- By:
- Publication type:
- Article
Enhanced SARS-CoV-2 humoral immunity following breakthrough infection builds upon the preexisting memory B cell pool.
- Published in:
- Science Immunology, 2023, v. 8, n. 89, p. 1, doi. 10.1126/sciimmunol.adk5845
- By:
- Publication type:
- Article
Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes.
- Published in:
- Science Immunology, 2022, v. 7, n. 75, p. 1, doi. 10.1126/sciimmunol.abq2427
- By:
- Publication type:
- Article
Immune memory to SARS-CoV-2 Omicron BA.1 breakthrough infections: To change the vaccine or not?
- Published in:
- Science Immunology, 2022, v. 7, n. 74, p. 1, doi. 10.1126/sciimmunol.abq5901
- By:
- Publication type:
- Article
Recall of preexisting cross-reactive B cell memory after Omicron BA.1 breakthrough infection.
- Published in:
- Science Immunology, 2022, v. 7, n. 73, p. 1, doi. 10.1126/sciimmunol.abq3511
- By:
- Publication type:
- Article
Analysis on the Epidemiological Characteristics of Breakthrough Varicella Cases and Incremental Effectiveness of 2-Dose Varicella Vaccine in China.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 160, doi. 10.3390/vaccines13020160
- By:
- Publication type:
- Article
Immunosuppressive Therapy Modifies Anti-Spike IgG Subclasses Distribution After Four Doses of mRNA Vaccination in a Cohort of Kidney Transplant Recipients.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 123, doi. 10.3390/vaccines13020123
- By:
- Publication type:
- Article
Immune Response and Breakthrough Infection Risk After SARS-CoV-2 Vaccines in Patients with Hemoglobinopathy: A Single Center Experience.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 111, doi. 10.3390/vaccines13020111
- By:
- Publication type:
- Article
COVID-19 Breakthrough Infections in Immune-Mediated Inflammatory Diseases: Data from the SUCCEED (Safety and Immunogenicity of COVID-19 Vaccines in Systemic Autoimmune-Mediated Inflammatory Diseases) Study.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 104, doi. 10.3390/vaccines13020104
- By:
- Publication type:
- Article
Analysis on the Epidemiological Characteristics of Breakthrough Varicella Cases and Incremental Effectiveness of 2-Dose Varicella Vaccine in China.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 160, doi. 10.3390/vaccines13020160
- By:
- Publication type:
- Article
Immunosuppressive Therapy Modifies Anti-Spike IgG Subclasses Distribution After Four Doses of mRNA Vaccination in a Cohort of Kidney Transplant Recipients.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 123, doi. 10.3390/vaccines13020123
- By:
- Publication type:
- Article
Immune Response and Breakthrough Infection Risk After SARS-CoV-2 Vaccines in Patients with Hemoglobinopathy: A Single Center Experience.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 111, doi. 10.3390/vaccines13020111
- By:
- Publication type:
- Article
COVID-19 Breakthrough Infections in Immune-Mediated Inflammatory Diseases: Data from the SUCCEED (Safety and Immunogenicity of COVID-19 Vaccines in Systemic Autoimmune-Mediated Inflammatory Diseases) Study.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 104, doi. 10.3390/vaccines13020104
- By:
- Publication type:
- Article
Current Status and Significance of Additional Vaccination with COVID-19 Vaccine in Japan—Considerations from Antibody Levels from Hybrid Immunity and Public Perceptions.
- Published in:
- Vaccines, 2024, v. 12, n. 12, p. 1413, doi. 10.3390/vaccines12121413
- By:
- Publication type:
- Article
Symptomatology and IgG Levels before and after SARS-CoV-2 Omicron Breakthrough Infections in Vaccinated Individuals.
- Published in:
- Vaccines, 2024, v. 12, n. 10, p. 1149, doi. 10.3390/vaccines12101149
- By:
- Publication type:
- Article
Maternal Preconception COVID-19 Vaccination and Its Protective Effect on Infants after a Breakthrough Infection during Pregnancy.
- Published in:
- Vaccines, 2024, v. 12, n. 10, p. 1132, doi. 10.3390/vaccines12101132
- By:
- Publication type:
- Article
Antibody Persistence and Risk of COVID-19 Infection: Insights from Modeling.
- Published in:
- Vaccines, 2024, v. 12, n. 9, p. 1079, doi. 10.3390/vaccines12091079
- By:
- Publication type:
- Article
Predictors of Hospitalization in Breakthrough COVID-19 among Fully Vaccinated Individuals with Immune-Mediated Rheumatic Diseases: Data from SAFER-Study.
- Published in:
- Vaccines, 2024, v. 12, n. 9, p. 1031, doi. 10.3390/vaccines12091031
- By:
- Publication type:
- Article
Understanding Mumps Dynamics: Epidemiological Traits and Breakthrough Infections in the Population under 15 Years of Age in Jiangsu Province, China, 2023.
- Published in:
- Vaccines, 2024, v. 12, n. 9, p. 986, doi. 10.3390/vaccines12090986
- By:
- Publication type:
- Article
Anti-RBD Antibody Levels and IFN-γ-Specific T Cell Response Are Associated with a More Rapid Swab Reversion in Patients with Multiple Sclerosis after the Booster Dose of COVID-19 Vaccination.
- Published in:
- Vaccines, 2024, v. 12, n. 8, p. 926, doi. 10.3390/vaccines12080926
- By:
- Publication type:
- Article
SARS-CoV-2 Vaccines: The Advantage of Mucosal Vaccine Delivery and Local Immunity.
- Published in:
- Vaccines, 2024, v. 12, n. 7, p. 795, doi. 10.3390/vaccines12070795
- By:
- Publication type:
- Article
Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine in People Living with HIV (PLWH).
- Published in:
- Vaccines, 2024, v. 12, n. 7, p. 785, doi. 10.3390/vaccines12070785
- By:
- Publication type:
- Article
Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study.
- Published in:
- Vaccines, 2024, v. 12, n. 7, p. 784, doi. 10.3390/vaccines12070784
- By:
- Publication type:
- Article
Durability of Humoral Responses after an Adapted SARS-CoV-2 mRNA Vaccine Dose in Hemodialysis Patients.
- Published in:
- Vaccines, 2024, v. 12, n. 7, p. 738, doi. 10.3390/vaccines12070738
- By:
- Publication type:
- Article
Breakthrough Measles among Vaccinated Adults Born during the Post-Soviet Transition Period in Mongolia.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 695, doi. 10.3390/vaccines12060695
- By:
- Publication type:
- Article
Impact of Nirsevimab Immunization on Pediatric Hospitalization Rates: A Systematic Review and Meta-Analysis (2024).
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 640, doi. 10.3390/vaccines12060640
- By:
- Publication type:
- Article
Immunogenicity and Cross-Protection Efficacy of a Genotype F-Derived Attenuated Virus Vaccine Candidate against Mumps Virus in Mice.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 595, doi. 10.3390/vaccines12060595
- By:
- Publication type:
- Article
Declining Levels of Neutralizing Antibodies to SARS-CoV-2 Omicron Variants Are Enhanced by Hybrid Immunity and Original/Omicron Bivalent Vaccination.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 564, doi. 10.3390/vaccines12060564
- By:
- Publication type:
- Article
Breakthrough Infections in SARS-CoV-2-Vaccinated Multiple Myeloma Patients Improve Cross-Protection against Omicron Variants.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 518, doi. 10.3390/vaccines12050518
- By:
- Publication type:
- Article
Serological Correlates of Protection Induced by COVID-19 Vaccination in the Working Age Population: A Systematic Review and Meta-Analysis.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 494, doi. 10.3390/vaccines12050494
- By:
- Publication type:
- Article
Harnessing T-Cells for Enhanced Vaccine Development against Viral Infections.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 478, doi. 10.3390/vaccines12050478
- By:
- Publication type:
- Article
Longitudinal Analysis of Humoral and Cellular Immune Response up to 6 Months after SARS-CoV-2 BA.5/BF.7/XBB Breakthrough Infection and BA.5/BF.7-XBB Reinfection.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 464, doi. 10.3390/vaccines12050464
- By:
- Publication type:
- Article
Correlates of Breakthrough SARS-CoV-2 Infections in People with HIV: Results from the CIHR CTN 328 Study.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 447, doi. 10.3390/vaccines12050447
- By:
- Publication type:
- Article
Changes in the Adaptive Cellular Repertoire after Infection with Different SARS-CoV-2 VOCs in a Cohort of Vaccinated Healthcare Workers.
- Published in:
- Vaccines, 2024, v. 12, n. 3, p. 230, doi. 10.3390/vaccines12030230
- By:
- Publication type:
- Article
Impact of Pre-Infection COVID-19 Vaccination on the Incidence and Severity of Post-COVID Syndrome: A Systematic Review and Meta-Analysis.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 189, doi. 10.3390/vaccines12020189
- By:
- Publication type:
- Article
Immunity to Tick-Borne Encephalitis Virus NS3 Protein Induced with a Recombinant Modified Vaccinia Virus Ankara Fails to Afford Mice Protection against TBEV Infection.
- Published in:
- Vaccines, 2024, v. 12, n. 1, p. 105, doi. 10.3390/vaccines12010105
- By:
- Publication type:
- Article
Predictors of Breakthrough SARS-CoV-2 Infection after Vaccination.
- Published in:
- Vaccines, 2024, v. 12, n. 1, p. 36, doi. 10.3390/vaccines12010036
- By:
- Publication type:
- Article
Humoral Immune Responses following COVID-19 Vaccinations among Adults in Tanzania.
- Published in:
- Vaccines, 2024, v. 12, n. 1, p. 22, doi. 10.3390/vaccines12010022
- By:
- Publication type:
- Article
Long-Term SARS-CoV-2-Specific Humoral and T Cell Responses after the BNT162b2 or BBIBP-CorV Booster and the Incidence of Breakthrough Infections among Healthcare Workers.
- Published in:
- Vaccines, 2024, v. 12, n. 1, p. 3, doi. 10.3390/vaccines12010003
- By:
- Publication type:
- Article
Long-Term Analyses of SARS-CoV-2 Humoral and T Cell Responses and Breakthrough SARS-CoV-2 Infections after Two Doses of BNT162b2 Followed by mRNA-1273 and Bivalent Omicron-Adapted BNT162b2 Vaccines: A Prospective Study over 2 Years in Non-Immunocompromised Individuals
- Published in:
- Vaccines, 2023, v. 11, n. 12, p. 1835, doi. 10.3390/vaccines11121835
- By:
- Publication type:
- Article
What Works for Controlling Meningitis Outbreaks: A Case Study from China.
- Published in:
- Vaccines, 2023, v. 11, n. 12, p. 1762, doi. 10.3390/vaccines11121762
- By:
- Publication type:
- Article
Characterization of Rotavirus Strains Responsible for Breakthrough Diarrheal Diseases among Zambian Children Using Whole Genome Sequencing.
- Published in:
- Vaccines, 2023, v. 11, n. 12, p. 1759, doi. 10.3390/vaccines11121759
- By:
- Publication type:
- Article
Primary and Recall Immune Responses to SARS-CoV-2 in Breakthrough Infection.
- Published in:
- Vaccines, 2023, v. 11, n. 11, p. 1705, doi. 10.3390/vaccines11111705
- By:
- Publication type:
- Article
An Analysis of the Neutralizing Antibodies against the Main SARS-CoV-2 Variants in Healthcare Workers (HCWs) Vaccinated against or Infected by SARS-CoV-2.
- Published in:
- Vaccines, 2023, v. 11, n. 11, p. 1702, doi. 10.3390/vaccines11111702
- By:
- Publication type:
- Article